Biomar Invests in Its Factory in Order to Produce Active Pharmaceutical Ingredients by Fermentation
Published: Tuesday, March 20, 2012 Last Updated: Tuesday, March 20, 2012
The biotech company announced that it has invested 2 million euros in the expansion of its León factory in order to produce kilograms of APIs (Active Pharmaceutical Ingredients) for the pharmacy, cosmetics, food, agriculture and energy sectors.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.